Abstract:The Gram-negative, opportunistic pathogen Pseudomonas aeruginosa has become a serious threat to global health, with increasing resistance towards even the most potent antibiotics. Like other bacteria, the pathogen produces a number of virulence factors that promote its pathogenicity. Of these, metallophores constitute an important group, able to scavenge metal ions from the surrounding environment to secure the metabolic functions of the bacterium. Pseudomonads produce the iron-chelating metallophore (siderophore) pyochelin (PCH), which, in addition to its iron scavenging ability, is an effector for the transcriptional regulator PchR in its Feᴵᴵᴵ-bound form (ferripyochelin). In the present study, docking studies predicted a major ferripyochelin binding site in PchR, which prompted the exploration of nor-pyochelin analogs to produce tight binding to PchR, and thereby establish a lasting effector response associated with upregulation of the genes involved in the PCH metabolism. In addition, we investigated the effects of using the analogs to bind the antimicrobial cations Gaᴵᴵᴵ and Inᴵᴵᴵ, leading to enhanced uptake and further disruption of the cell machinery. Selected analogs of nor-pyochelin (nor-PCH) were synthesized and their Gaᴵᴵᴵ and Inᴵᴵᴵ-based complexes were assessed for antimicrobial activity. The results indicate that the Gaᴵᴵᴵ-complexes inhibit the pathogens under iron-limited conditions, while the Inᴵᴵᴵ-based systems are more effective in iron-rich media. Several of the Gaᴵᴵᴵ-complexes were shown to be highly effective against an MDR P. aeruginosa clinical isolate, with minimum inhibitory concentrations (MICs) of ≤1 µg/mL. Similarly, two of the Inᴵᴵᴵ-based systems were particularly effective against the isolate, with an MIC of 8 µg/mL. These results show high promise in comparison with other, traditionally potent antibiotics. Preliminary mechanistic investigations of the antimicrobial activity using pseudomonal transposon mutants suggested that the inhibitory effects of the Inᴵᴵᴵ-based systems could be due to acute iron deficiency as a result of Inᴵᴵᴵ-bound bacterioferritin (BfrB). Cytotoxiticy analysis indicated that the compounds generally show low toxicity toward mammalian cells under the experimental conditions.

Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group

Berberine-INF55 (5-nitro-2-phenylindole) hybrid antimicrobials: effects of varying the relative orientation of the berberine and INF55 components

Discovery of Natural Berberine-Derived Nitroimidazoles As Potentially Multi-Targeting Agents Against Drug-Resistant Escherichia Coli

Nosiheptide Analogues As Potential Antibacterial Agents Via Dehydroalanine Region Modifications: Semi-synthesis, Antimicrobial Activity and Molecular Docking Study.

Discovery of 2-Aminothiazolyl Berberine Derivatives As Effectively Antibacterial Agents Toward Clinically Drug-Resistant Gram-negative Acinetobacter Baumanii.

Synthesis and bioactive evaluation of novel hybrids of metronidazole and berberine as new type of antimicrobial agents and their transportation behavior by human serum albumin.

Design, synthesis and biological evaluation of berberine-benzimidazole hybrids as new type of potentially DNA-targeting antimicrobial agents.

Novel Benzothiazole‒urea Hybrids: Design, Synthesis and Biological Activity As Potent Anti-Bacterial Agents Against MRSA.

Role of Berberine in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections

Inhibition of polymorphic MexXY‐OprM efflux system in Pseudomonas aeruginosa clinical isolates by Berberine derivatives

Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees

Antimicrobial Potency of Nor-Pyochelin Analogs and Their Cation Complexes Against Multidrug-Resistant Pathogens

Synthesis and antibacterial evaluation of new naphthalimide-coumarin hybrids against multidrug-resistant S. aureus and M. tuberculosis

Potential antibacterial ethanol-bridged purine azole hybrids as dual-targeting inhibitors of MRSA

Novel Schiff Base‐conjugated para ‐Aminobenzenesulfonamide Indole Hybrids as Potentially Muti‐targeting Blockers against Staphylococcus aureus

Efflux pump inhibitory potential of indole derivatives as an arsenal against norA over-expressing Staphylococcus aureus

Conjugates of Chloramphenicol Amine and Berberine as Antimicrobial Agents

Novel Small-Molecule Hybrid-Antibacterial Agents against S. aureus and MRSA Strains

Evolution and Antibacterial Evaluation of 8-Hydroxy-cycloberberine Derivatives as a Novel Family of Antibacterial Agents Against MRSA

Identification of novel natural inhibitor for NorM – a multidrug and toxic compound extrusion transporter – an insilico molecular modeling and simulation studies

Molecular Simplification of Natural Products: Synthesis, Antibacterial Activity, and Molecular Docking Studies of Berberine Open Models